X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Piramal Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ADCOCK INGRAM (S. Africa) - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   ADCOCK INGRAM
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-17
ADCOCK INGRAM
Jun-14
PIRAMAL ENTERPRISES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,095399-   
Low Rs1,025288-   
Sales per share (Unadj.) Rs492.8118.8-  
Earnings per share (Unadj.) Rs72.6-29.9-  
Cash flow per share (Unadj.) Rs94.7-24.8-  
Dividends per share (Unadj.) Rs21.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs862.593.3-  
Shares outstanding (eoy) m172.56168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.22.9 109.4%   
Avg P/E ratio x21.5-11.5 -187.2%  
P/CF ratio (eoy) x16.5-13.9 -118.9%  
Price / Book Value ratio x1.83.7 49.1%  
Dividend payout %28.90-   
Avg Mkt Cap Rs m269,19458,031 463.9%   
No. of employees `0004.04.3 93.5%   
Total wages/salary Rs m17,9393,642 492.5%   
Avg. sales/employee Rs Th21,190.34,671.9 453.6%   
Avg. wages/employee Rs Th4,470.1848.4 526.9%   
Avg. net profit/employee Rs Th3,120.0-1,177.2 -265.0%   
INCOME DATA
Net Sales Rs m85,03720,056 424.0%  
Other income Rs m2,338140 1,664.3%   
Total revenues Rs m87,37420,197 432.6%   
Gross profit Rs m34,991-3,476 -1,006.8%  
Depreciation Rs m3,817866 441.0%   
Interest Rs m20,310543 3,738.3%   
Profit before tax Rs m13,202-4,744 -278.3%   
Minority Interest Rs m1,699-13 -12,847.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1000-   
Tax Rs m2,281296 769.5%   
Profit after tax Rs m12,520-5,054 -247.7%  
Gross profit margin %41.1-17.3 -237.5%  
Effective tax rate %17.3-6.2 -276.5%   
Net profit margin %14.7-25.2 -58.4%  
BALANCE SHEET DATA
Current assets Rs m87,59014,690 596.3%   
Current liabilities Rs m185,5788,265 2,245.4%   
Net working cap to sales %-115.232.0 -359.7%  
Current ratio x0.51.8 26.6%  
Inventory Days Days31111 28.0%  
Debtors Days Days48124 38.4%  
Net fixed assets Rs m108,5238,563 1,267.4%   
Share capital Rs m34593 370.6%   
"Free" reserves Rs m148,4810-   
Net worth Rs m148,82615,742 945.4%   
Long term debt Rs m144,9575,532 2,620.3%   
Total assets Rs m482,39429,738 1,622.1%  
Interest coverage x1.7-7.7 -21.3%   
Debt to equity ratio x1.00.4 277.2%  
Sales to assets ratio x0.20.7 26.1%   
Return on assets %6.8-15.2 -44.9%  
Return on equity %8.4-32.1 -26.2%  
Return on capital %12.0-19.8 -60.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,8510-   
CASH FLOW
From Operations Rs m-100,3931,712 -5,864.2%  
From Investments Rs m-24,202-526 4,604.2%  
From Financial Activity Rs m135,7055,021 2,702.9%  
Net Cashflow Rs m11,1106,207 179.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.51 Rs / ZAR

Compare PIRAMAL ENTERPRISES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: J.B.CHEMICALS  ELDER PHARMA  ALEMBIC PHARMA  GSK PHARMA  ORCHID PHARMA LTD  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Feb 16, 2018 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS